ReviewFrontiers in cellular and infection microbiology2026
Recent advances in early screening and diagnosis of sepsis: a narrative review.
Review in Frontiers in cellular and infection microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection. Characterized by acute onset, rapid progression and high mortality, it poses a major global public health challenge in critical care medicine. Early accurate screening and diagnosis are crucial to improving patient prognosis and reducing mortality. In recent years, with the rapid advancement of medical technology, early screening and diagnostic strategies for sepsis have been continuously updated. Diagnostic approaches have evolved from traditional clinical scoring systems such as the The Sequential Organ Failure Assessment (SOFA) score and routine inflammatory biomarker detection to novel biomarkers including soluble Triggering Receptor Expressed on Myeloid cells-1(sTREM-1) and soluble cluster of differentiation 14 subtype (presepsin), as well as intelligent diagnostic techniques represented by Sepsis ImmunoScore and machine learning algorithms. Based on recent domestic and international research evidence, this narrative review summarizes the latest advances in early screening and diagnosis of sepsis, analyzes the strengths and limitations of various modalities, and provides references for early clinical identification and precise diagnosis of sepsis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.